Scientists at Novo Nordisk in Denmark have applied flow chemistry to enhance the cleavage of oligonucleotides. Utilizing Vapourtec's R-Series flow chemistry system to undertake their research, the ...

Oligonucleotide therapeutics are becoming increasingly popular, with scientists developing treatments for rare diseases, cancer, and respiratory disorders. To ensure their quality, researchers must ...

GSK has acquired Elsie Biotechnologies, an oligonucleotide therapeutics company, in a deal worth up to $50 million. Oligo therapy aims to modulate gene expression by binding a small strand of DNA or ...

Therapeutic oligonucleotides act on different stages of pathological gene expression. Standard schematic of oligonucleotide activities in pathogenesis disease progression. Decoys bind to transcription ...